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Abstract
Reports from countries with a high prevalence of 
Helicobacter pylori (H pylori) infection do not show a 
proportionately high prevalence of duodenal ulceration, 
suggesting the possibility that H pylori cannot be a 
primary cause of duodenal ulceration. It has been 
mooted that this discrepancy might be explained 
by variations in the prevalence of virulence factors 
in different populations. The aim of this paper is to 
determine whether the published literature gives support 
to this possibility. The relevant literature was reviewed 
and analyzed separately for countries with a high and 
low prevalence of H pylori  infection and virulence 
factors. Although virulent strains of H pylori were 
signiﬁ  cantly more often present in patients with duodenal 
ulcer than without the disease in countries with a low 
prevalence of H pylori infection in the population, there 
was no difference in the prevalence of virulence factors 
between duodenal ulcer, non - ulcer dyspepsia or normal 
subjects in many countries, where the prevalence of 
both H pylori infection and of virulence factors was high. 
In these countries, the presence of virulence factors 
was not predictive the clinical outcome. To explain the 
association between virulence factors and duodenal 
ulcer in countries where H pylori prevalence is low, 
only two papers were found that give little support to 
the usual model proposed, namely that organisms with 
the virulence factors are more likely than those without 
them to initiate a duodenal ulcer. We offer an alternative 
hypothesis that suggests virulence factors are more likely 
to interfere with the healing of a previously produced 
ulcer. The presence of virulence factors only correlates 
with the prevalence of duodenal ulcer in countries 
where the prevalence of H pylori is low. There is very 
little evidence that virulence factors initiate duodenal 
ulceration, but they may be related to failure of the ulcer 
to heal.
© 2006 The WJG Press. All rights reserved.
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HELICOBACTER PYLORI VIRULENCE 
FACTORS AND DUODENAL ULCERATION
Following Warren and Marshall’s historic paper in 
1984
[1], evidence for an association between duodenal 
ulceration and Helicobacter pylori (H pylori) infection has 
been strengthened. Earlier publications, however, were 
from developed countries, where the overall prevalence 
of H pylori infection was between 40% and 60%. The 
difﬁ  cult problem that remained was why everyone with H 
pylori infection did not develop duodenal ulceration. This 
problem was increased by the reporting of the “African 
enigma” from the savannah regions of the West Coast of 
Africa
[2,3], where the prevalence of H pylori infection was 
much higher ( > 90%), but the prevalence of duodenal 
ulceration was relatively low. This was followed by an 
increasing number of reports from other countries, where 
a high prevalence of H pylori infection did not correlate 














When it was later reported that some strains of 
H pylori were more virulent than others, this seemed 
a possible explanation of the paradox. In the more 
developed countries, the virulent factors, cagA (cytotoxin 
associated antigen) and vacA (vacuolating factor), were 
present in between 40% and 60% of H pylori strains, and 
it was suggested that these strains might prove to be the 
causal factors in duodenal ulceration and account for the 
discrepancies
[19-24]. 
There is no doubt about the association of these fac-
tors with duodenal ulceration in countries, where the 
overall prevalence of H pylori infection and virulence fac-
tors is relatively low, compared with countries where it 
is high. However, an increasing number of reports from 
countries, where H pylori infection is almost ubiquitous
(70-90+%) and 77%-88% of the strains carry the viru-Tovey FI et al.  H pylori virulence factors and duodenal ulceration                                                           7
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lence factors cagA and vacA, have shown no relationship 





















[63]). A few similar reports 







Most cagA positive strains also carry the vacA gene. 
When present, the cagA gene secretes the toxic CagA 
protein, but not all vacA strains secrete a toxigenic protein. 
There are different allelic types of vacA, the types vacAs1 
and vacAs1m1 are toxic and strongly associated with 
duodenal ulceration, mostly in countries with a relatively 
low prevalence of H pylori infection. Once again, however, 
reports from countries with a high prevalence of these 




Other virulence markers have been reported: ice-
A1gene [induced by contact with gastric epithelium] and 
babA2 gene (blood group antigen binding adhesin), which 
binds to Lewis B present on gastric epithelial cells, show 
an association with duodenal ulceration in countries, where 
the prevalence of H pylori and these strains is low. How-
ever, reports from many countries with a high prevalence 
of H pylori and these virulence markers again show that in 




Thus, there remains the anomaly that, although 
duodenal ulceration is strongly associated with H pylori 
infection and certain virulence factors in countries with 
a relatively low prevalence of both H pylori infection and 
virulence factors, this association disappears in many 
countries
[75] where these prevalences are high, and where 
H pylori infection and virulence factors do not predict 
clinical outcome. This casts doubt upon whether H pylori 
initiates duodenal ulcer. This doubt is strongly supported 
by the ﬁ  nding that most patients with a short history
[76]  or 
all with less than 6 month`s history
[77] of duodenal ulcer 
symptoms were uninfected with H pylori.
Nonetheless the importance of H pylori infection and 
virulence factors cannot be dismissed. There is no doubt 
that the eradication of H pylori infection leads to healing 
of duodenal ulceration and the risk of recurrence is 
greatly reduced. There is also no doubt about the strong 
association of H pylori and virulence factors with duodenal 
ulceration in countries where the overall prevalence of
H pylori infection is relatively low.
The tendency for H pylori to be absent in the early 
case suggests that the organism is not the primary cause 
producing duodenal ulcer. The evidence that the chronic 
course of healing→recurrence→etc. of the typical chronic 
duodenal ulcer is converted in most cases into stable 
healing by eradicating H pylori suggests that the organism, 
when present, interferes with the healing process.
There remains the question why the virulence factors 
are related to the presence of duodenal ulceration in the 
countries with a low prevalence of H pylori infection. It 
is possible that colonization of nearby areas of antral 
epithelium or of gastric metaplasia in the duodenum by
H pylori leads to the local release of toxins that produces 
the duodenal ulcer. However, this straightforward model 
has not been substantiated. The toxins concerned have 
been demonstrated and their toxic effects are determined 
mostly by their interaction with gastric epithelium
[19] and 
there are only two papers reporting about the damage 
caused by toxins to duodenal mucosa. One paper
[78] reports 
about the prevention of healing of mechanically abraded 
human duodenal epithelium in vitro by strains of wild
H pylori, particularly those carrying the vacA gene, and also 
by supernatant fluid containing the vacA cytotoxin. The 
other paper
[79] reports about increased duodenal mucosal 
permeability, when exposed to H pylori culture ﬂ  uid in rats. 
It must be emphasized that neither paper reports about 
the initiation of ulceration.
As an alternative explanation, we advance the following 
more complicated model which we have partly suggested 
before
[11,77]. H pylori is killed by excess acid
[80,81]. In 
countries, where the overall prevalence of H pylori infection 
is low, duodenal ulcer patients initially may be free from 
H pylori infection because of their high acid output. In the 
early stages of ulceration, many subjects, prior to seeking 
deﬁ  nitive treatment, control their symptoms with antacids, 
some including H2 antagonists, which are available without 
prescription. This reduces the defense against infection 
with the organism in patients who have hitherto been 
resistant (since they start H pylori negative). This partial 
reduction in resistance can be overcome by virulent, but 
not by non - virulent strains, so there is an association 
between the virulent strains and the chronic ulcer patients, 
most of whom have become H pylori - positive for the 
organism by 6 months time
[76,77]. The high baseline of 
infection with virulent strains, in the countries with a high 
prevalence, obscures this effect.
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